# Stephane Legastelois

> Stephane Legastelois is a Series A investor backing Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Sep 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/stephane-legastelois-1110551/?originalSubdomain=fr

Stephane Legastelois is a President at 33 Californie

## Contacts

5 contacts available for Stephane Legastelois: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/stephane-legastelois?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brenus Pharma | Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $25M | Series A | Sep 18, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Angelor](https://shizune.co/investors/profile/angelor) — VC Fund, 1 deal together
- [Crédit Agricole Centre-Est](https://shizune.co/investors/profile/cr%C3%A9dit-agricole-centre-est) — VC Fund, 1 deal together
- [Investsud](https://shizune.co/investors/profile/investsud) — VC Fund, 1 deal together
- [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest) — VC Fund, 1 deal together
- [UI Investissement](https://shizune.co/investors/profile/ui-gestion) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in France](https://shizune.co/investors/biotechnology-angel-investors-france)
- [Biotech Angel Investors in France](https://shizune.co/investors/biotech-angel-investors-france)

## FAQ

### What does Stephane Legastelois invest in?

Stephane Legastelois invests primarily in Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Stephane Legastelois?

Public channels for Stephane Legastelois include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Stephane Legastelois last invest?

The most recent investment recorded for Stephane Legastelois closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co